Thus, evidence is accumulating that ascorbic acid does not have the same robust positive effect on myelination and functional abilities as was shown in the PMP22 over-expressing mouse model [11] in neither child nor (young) adult CMT1A patients [25,26]. The gene discussed is PMP22; the disease is Charcot-Marie-Tooth disease type 1A.